Näytä suppeat kuvailutiedot

Magnetic resonance-guided ablation of liver tumors: A systematic review and pooled analysis

Roberto Blanco; Yujun Xu; Chengli Li; Jianfeng Xiang; Ming Liu; Xiangmeng He; Rongbin Lu; Ligang Wang

dc.contributor.authorRoberto Blanco
dc.contributor.authorYujun Xu
dc.contributor.authorChengli Li
dc.contributor.authorJianfeng Xiang
dc.contributor.authorMing Liu
dc.contributor.authorXiangmeng He
dc.contributor.authorRongbin Lu
dc.contributor.authorLigang Wang
dc.date.accessioned2022-10-28T12:35:38Z
dc.date.available2022-10-28T12:35:38Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/160644
dc.description.abstract<p><strong>Purpose: </strong>The purpose of this study is to study the clinical outcomes of different types of magnetic resonance (MR)-guided ablation for the treatment of liver tumors by performing a systematic review and pooled analysis.</p><p><strong>Materials and methods: </strong>A comprehensive literature search was performed for clinical trials published from January 1997 to October 2019 in PubMed, the Web of Science, Embase, and the Cochrane Library. Pooled analyses were performed to obtain the complete ablation (CA), complication, progression-free survival (PFS), and overall survival (OS) rates.</p><p><strong>Results: </strong>Thirty studies were eligible, including four studies on MR-guided microwave ablation (MWA); 14 studies on MR-guided radiofrequency ablation (RFA); one study on both MR-guided MWA and RFA; eight studies on MR-guided, laser-induced thermotherapy (LITT); two studies on MR-guided percutaneous cryoablation (PC); and one study on MR-guided percutaneous ethanol injection (PEI). The CA rates in patients who underwent RFA, MWA, LITT, PC, and PEI were 95.60%, 98.86%, 77.78%, 47.92%, and 85.71%, respectively. The most frequent complications were pain (27.66%, 13/47) and postablation syndrome (27.66%, 13/47) in the PC group; pleural effusion (8.11%, 119/1,468) and subcapsular hematoma (2.25%, 33/1,468) in the LITT group; pleural effusion (2.67%, 2/75) in the MWA group; and subcapsular hematoma (4.18%, 20/478) and post-ablation syndrome (2.93%, 14/478) in the RFA group. There were few studies reporting PFS and OS.</p><p><strong>Conclusions: </strong>MR-guided ablation is a practicable alternative treatment for liver tumors, especially MR-guided RFA and MWA, which have high rates of CA and low occurrences of complications.</p>
dc.language.isoen
dc.publisherAssociation of Radiation Oncologists of India
dc.titleMagnetic resonance-guided ablation of liver tumors: A systematic review and pooled analysis
dc.identifier.urnURN:NBN:fi-fe2022021519196
dc.relation.volume16
dc.contributor.organizationfi=tyks, vsshp|en=tyks, vsshp|
dc.contributor.organizationfi=diagnostinen radiologia|en=Diagnostic Radiology|
dc.contributor.organization-code2607303
dc.converis.publication-id51128644
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/51128644
dc.format.pagerange1093
dc.format.pagerange1099
dc.identifier.jour-issn0973-1482
dc.okm.affiliatedauthorBlanco Sequeiros, Roberto
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countryIndiaen_GB
dc.publisher.countryIntiafi_FI
dc.publisher.country-codeIN
dc.relation.doi10.4103/jcrt.JCRT_1115_19
dc.relation.ispartofjournalJournal of Cancer Research and Therapeutics
dc.relation.issue5
dc.year.issued2020


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot